| 尋媶嬈愌 |
 |
| 墷暥丒墷暥憤愢 |
2023擭
|
Kawamata M, Suzuki H, Kimura R,Suzuki A
Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs.
Nat Biomed Eng,in press,37037965. 丂亂PubMed亃
|
| 2020擭 |
Katsuda T., Kawamata M., Inoue A., Yamaguchi T., Abe M., Ochiya T.
Long-term maintenance of functional primary human hepatocytes
using small molecules.
FEBS Lett., 594(1):114-125. 亂PubMed亃
|
| 2019擭 |
Terada M., Kawamata M., Kimura R., Sekiya S., Nagamatsu G.,
Hayashi K., Horisawa K., Suzuki A.
Generation of Nanog reporter micethat distinguish pluripotent stem cells
from unipotent primordial germ cells.
Genesis. 57(11-12):e23334. 亂PubMed亃
|
| 2018擭 |
Yoshimura A., Adachi N., Matsuno H., Kawamata M., Yoshioka Y.,
Kikuchi H., Odaka H., Numakawa T., Kunugi H., Ochiya T., Tamai Y.
The Sox2 promoter-driven CD63-GFP transgenic rat model allows
tracking of neural stem cell-derived extracellular vesicles.
Dis Model Mech. 30;11(1). pii: dmm028779.亂PubMed亃
|
| 2017擭 |
Kawamata M., Katsuda T., Yamada Y., Ochiya T.
In vitro reconstitution of breast cancer heterogeneity with multipotent
cancer stem cells using small molecules.
Biochem Biophys Res Commun. 2017, 482(4):750-75
亂PubMed亃
Kawamata M., Suzuki A.
Cell fate modification toward the hepatic lineageby extrinsic factors.
J Biochem. 162(1):11-16. 亂PubMed亃
Katsuda T., Kawamata M., Hagiwara K., Takahashi RU., Yamamoto Y.,
Camargo FD, Ochiya T.
Conversion of terminally committed hepatocytes to culturable bipotent
progenitor cells with regenerative capacity.
Cell Stem Cell, 2017, 20(1):41-55. 亂PubMed亃
|
| 2016擭 |
Yoshimura A., Kawamata M., Yoshioka Y., Katsuda T., Kikuchi H., Nagai Y.,
Adachi N., Numakawa T., Kunugi H., Ochiya T., Tamai Y.
Generation of a novel transgenic rat model for tracing extracellular vesicles
in body fluids.
Sci Rep, 2016, 6: 31172 亂PubMed亃
|
| 2015擭 |
Kawaharada K., Kawamata M., Ochiya T.丂
Rat embryonic stem cells create new era in development of genetically
manipulated rat models.
World J Stem Cells. 26;7(7):1054-63 亂PubMed亃
|
| 2014擭 |
Katsuda T., Ikeda S., Yoshioka Y., Kosaka N., Kawamata M., Ochiya T.
Physiological and pathological relevance of secretory microRNAs and
perspective on their clinical application.
Biol Chem, 395(4):365-73 亂PubMed亃
|
| 2013擭 |
Hong J, He H, Bui P, Ryba-White B, Rumi MA, Soares MJ, Dutta D,
Paul S, Kawamata M., Ochiya T.,Ying QL, Rajanahalli P, Weiss ML.
A Focused Microarray for Screening Rat Embryonic Stem Cell Lines.
Stem Cells Dev, 22(3):431-43 亂PubMed亃
|
| 2012擭 |
Kawamata M., Ochiya T.
Two distinct knockout approaches highlight a critical role for p53
in rat development.
Sci Rep, 2: 945 亂PubMed亃
|
| 2011擭 |
Kawamata M., Ochiya T.
Gene-manipulated embryonic stem cells forrat transgenesis.
Cell Mol Life Sci. 68(11):1911-5 亂PubMed亃
Kawamata M., Ochiya T.
Establishment of embryonic stem cells and generation of
genetically modified rats.
InTech,p383-96 亂PubMed亃
|
| 2010擭 |
Kawamata M., Ochiya T.
Generation of genetically modified rats from embryonic stem cells.
Proc Natl Acad Sci USA.10;107(32):14223-8
亂PubMed亃
Takeshita F., Patrawala L, Osaki M., Takahashi RU, Yamamoto Y,
Kosaka N., Kawamata M., Kelnar K, Bader AG, Brown D, Ochiya T.
Systemic delivery of synthetic microRNA-16 inhibits the growth of
metastatic prostate tumors via downregulation of multiple cell-cycle genes.
Mol Ther, 18(1):181-7.亂PubMed亃
Kawamata M., Ochiya T.
Establishment of embryonic stem cellsfrom rat blastocysts.
Methods Mol Biol. 597:169-77 亂PubMed亃
|
| 2008擭 |
Kawamata M., Yoshida M., Sugimoto Y., Kimura T., Tonomura Y.,
Takayanagi Y., Yanagisawa T., Nishimori K.
Infusion of oxytocininduces successful delivery in prostanoid
FP-receptor-deficient mice.
Mol Cell Endocrinol. 283(1-2):32-7亂PubMed亃
Banas A, Teratani T., Yamamoto Y., Tokuhara M., Takeshita F.,
Kawamata M., Kato T., Okochi H., Ochiya T.
In vivo therapeutic potential of human Adipose Tissue Mesenchymal
Stem Cells(AT-MSCs) after transplantation into mice with liver injury.
Stem Cells, 26(10):2705-12 亂PubMed亃
Ueda S., Kawamata M., Teratani T., Shimizu T., Tamai Y., Ogawa H.,
Hayashi K., Tsuda H., Ochiya T.
Establishment of rat embryonic stem cells and making of chimera rats.
PLoS One, 3(7):e2800 亂PubMed亃
Nishimori K., Takayanagi Y., Yoshida M., Kasahara Y., Young LJ,
Kawamata M.
New aspects of oxytocin receptor function revealed by knockout mice:
sociosexual behaviour and control of energy balance.
Prog Brain Res. 170:79-90 亂PubMed亃
|
| 2007擭 |
Kawamata M., Inoue H., Nishimori K.
Male-specific function of Dmrt7 by sexually dimorphic translation
in mouse testis.
Sex Dev.2007;1(5):297-304亂PubMed亃
Kawamata M., Tonomura Y., Kimura T., Sugimoto Y., Yanagisawa T.,
Nishimori K.
Oxytocin-induced phasic and tonic contractions are modulated
by the contractilemachinery rather than the quantity of oxytocin receptor.
Am J Physiol Endocrinol Metab. 292(4):E992-9
亂PubMed亃
|
| 2006擭 |
Kawamata M., Nishimori K.
Mice deficient in Dmrt7 show infertility with spermatogenic arrest at
pachytene stage.
FEBS Lett. 580(27):6442-6 亂PubMed亃
|
| 2005擭 |
Takayanagi Y., Yoshida M., Bielsky IF, Ross HE, Kawamata M., Onaka T.,
Yanagisawa T., Kimura T., Matzuk MM, Young LJ, Nishimori K.
Pervasive social deficits, but normal parturition, in oxytocin
receptor-deficient mice.
Proc Natl Acad Sci USA.102(44):16096-101 亂PubMed亃
|
| 2004擭 |
Kawamata M., Tonomura Y., Kimura T., Yanagisawa T., Nishimori K.
The differential coupling of oxytocin receptors to uterine contractions
in murine estrous cycle.
Biochem Biophys Res Commun. 321(3):695-9亂PubMed亃
|
| 2003擭 |
Kawamata M., Mitsui-Saito M., Kimura T., Takayanagi Y., Yanagisawa T.,
Nishimori K.
Vasopressin-induced contraction of uterus is mediated solely by
the oxytocin receptor in mice, but not in humans.
Eur J Pharmacol 472(3): 229-34 亂PubMed亃 |
|
|
 |
|
